# Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)

> **NCT05227534** · NA · RECRUITING · sponsor: **Guangzhou Burning Rock Dx Co., Ltd.** · enrollment: 12500 (estimated)

## Conditions studied

- Cancer
- Early Detection of Cancer
- Circulating Cell-free DNA

## Interventions

- **DEVICE:** OverC multi-cancer detection blood test

## Key facts

- **NCT ID:** NCT05227534
- **Lead sponsor:** Guangzhou Burning Rock Dx Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 12500 (ESTIMATED)
- **Last updated:** 2022-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227534, "Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05227534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*